Jed Dorsheimer, William Blair analyst, joins 'The Exchange' to discuss Tesla's chip deal with Samsung and what it means for ...

Vertiv Holdings (NYSE:VRT) on Monday was rated Outperform in new research coverage by analysts at investment firm William ...

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) reported upbeat second-quarter earnings and 2025 guidance on Thursday. The company ...

Lenz Therapeutics has earned the FDA’s go-ahead for its aceclidine eye drop to crack the large presbyopia market, where past ...

Detailed price information for Exlservice Holdings (EXLS-Q) from The Globe and Mail including charting and trades.

William Blair cheers Tesla-Samsung chip deal but keeps TSLA at Hold, citing auto margin woes and valuation concerns.

In addition, The Allstate Corporation (NYSE:ALL) is taking advantage of a far better auto loss environment and employing ...

In CCC v AAC [2025] HKCFI 2987, Sir William Blair, sitting as Deputy High Court Judge in the Hong Kong Court of First Instance (“Court”), rejected ...

William Blair analyst Matt Larew maintained a Hold rating on Amedisys today. The company’s shares closed yesterday at $97.52. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing ...

After beating quarterly earnings expectations and raising its full-year sales outlook from a previously forecast decline, ...

Mastercard eased concerns about a potential slowdown in consumer spending after beating Wall Street estimates for ...

Rumors of Biogen’s disagreements with Eisai have been greatly exaggerated, CEO Chris Viehbacher said during a second quarter ...